Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance

Journal of Clinical Investigation

Volumn 117, Issue 6, 2007, Pages 1679-1689

  Liu, Li ^a   Zhang, Yiying ^a   Chen, Nancy ^a   Shi, Xiaojing ^a   Tsang, Bonny ^a   Yu, Yi Hao ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DIACYLGLYCEROL ACYLTRANSFERASE; DIACYLGLYCEROL ACYLTRANSFERASE 1; FATTY ACID; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME REGULATION; ENZYMOLOGY; EXERCISE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID STORAGE; LIPOGENESIS; MOUSE; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; BASE SEQUENCE; DIABETES MELLITUS, TYPE 2; DIACYLGLYCEROL O-ACYLTRANSFERASE; DIETARY FATS; DNA PRIMERS; EXERTION; HUMANS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE, SKELETAL; TRIGLYCERIDES; UP-REGULATION;

EID: 34249894505     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30565     Document Type: Article

References (81)

1. Unger, R.H. 2002. Lipotoxic diseases. Annu. Rev. Med. 53:319-336.
2. Yu, Y.H., and Ginsberg, H.N. 2004. The role of acyl-CoA:diacylglycerol acyltransferase (DGAT) in energy metabolism. Ann. Med. 36:252-261.
3. Phillips, D.I., et al. 1996. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism. 45:947-950.
4. Ebeling, P., et al. 1998. Intramuscular triglyceride content is increased in IDDM. Diabetologia. 41:111-115.
5. Manco, M., et al. 2000. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism. 49:220-224.
6. Borkman, M., et al. 1993. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N. Engl. J. Med. 328:238-244.
7. Pan, D.A., et al. 1997. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes. 46:983-988.
8. Perseghin, G., et al. 1999. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes. 48:1600-1606.
9. Virkamaki, A., et al. 2001. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes. 50:2337-2343.
10. Krssak, M., et al. 1999. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia. 42:113-116.
11. Rosa, G., et al. 2003. Decreased muscle acetyl-coenzyme A carboxylase 2 mRNA and insulin resistance in formerly obese subjects. Obes. Res. 11:1306-1312.
12. Heron-Milhavet, L., et al. 2004. Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice. Endocrinology. 145:4667-4676.
13. Shimomura, I., et al. 1999. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 401:73-76.
14. Oral, E.A., et al. 2002. Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med. 346:570-578.
15. Qu, X., Seale, J.P., and Donnelly, R. 1999. Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats - effects of feeding. J. Endocrinol. 162:207-214.
16. Ellis, B.A., et al. 2000. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am. J. Physiol. Endocrinol. Metab. 279:E554-E560.
17. Kim, J.K., et al. 2001. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 98:7522-7527.
18. Franch, J., et al. 2002. Acyl-CoA binding protein expression is fiber type-specific and elevated in muscles from the obese insulin-resistant Zucker rat. Diabetes. 51:449-454.
19. Yu, C., et al. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277:50230-50236.
20. Lee, J.S., et al. 2006. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J. Appl. Physiol. 100:1467-1474.
21. Hoppeler, H., et al. 1985. Endurance training in humans: aerobic capacity and structure of skeletal muscle. J. Appl. Physiol. 59:320-327.
22. Goodpaster, B.H., et al. 2001. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J. Clin. Endocrinol. Metab. 86:5755-5761.
23. Schenk, S., et al. 2005. Postexercise insulin sensitivity is not impaired after an overnight lipid infusion. Am. J. Physiol. Endocrinol. Metab. 288:E519-E525.
24. Decombaz, J., et al. 2001. Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:R760-R769.
25. Bogardus, C., et al. 1984. Effects of physical training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and non-insulin-dependent diabetes mellitus. Diabetes. 33:311-318.
26. DeFronzo, R.A., Sherwin, R.S., and Kraemer, N. 1987. Effect of physical training on insulin action in obesity. Diabetes. 36:1379-1385.
27. Richter, E.A., et al. 1989. Effect of exercise on insulin action in human skeletal muscle. J. Appl. Physiol. 66:876-885.
28. Perseghin, G., et al. 1996. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N. Engl. J. Med. 335:1357-1362.
29. Dela, F., et al. 1995. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes. 44:1010-1020.
30. Goodpaster, B.H., Katsiaras, A., and Kelley, D.E. 2003. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes. 52:2191-2197.
31. Short, K.R., et al. 2003. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes. 52:1888-1896.
32. Bruce, C.R., et al. 2006. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am. J. Physiol. Endocrinol. Metab. 291:E99-E107.
33. Russell, A.P. 2004. Lipotoxicity: the obese and endurance-trained paradox. Int. J. Obes. Relat. Metab. Disord. 28(Suppl. 4):S66-S71.
34. Bassel-Duby, R., and Olson, E.N. 2006. Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 75:19-37.
35. Etgen, G.J., Jr., et al. 1996. Glucose transport and cell surface GLUT-4 protein in skeletal muscle of the obese Zucker rat. Am. J. Physiol. 271:E294-E301.
36. Hickey, M.S., et al. 1995. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am. J. Physiol. 268:E453-E457.
37. Song, X.M., et al. 1999. Muscle fiber type specificity in insulin signal transduction. Am. J. Physiol. 277:R1690-R1696.
38. Henriksen, E.J., et al. 1990. Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am. J. Physiol. 259:E593-E598.
39. Ryder, J.W., et al. 2003. Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways. J. Biol. Chem. 278:44298-44304.
40. Bell, R.M., and Coleman, R.A. 1980. Enzymes of glycerolipid synthesis in eukaryotes. Annu. Rev. Biochem. 49:459-487.
41. Lehner, R., and Kuksis, A. 1996. Biosynthesis of triacylglycerols. Prog. Lipid Res. 35:169-201.
42. Bagnato, C., and Igal, R.A. 2003. Overexpression of diacylglycerol acyltransferase-1 reduces phospholipid synthesis, proliferation, and invasiveness in simian virus 40-transformed human lung fibroblasts. J. Biol. Chem. 278:52203-52211.
43. Oelkers, P., et al. 1998. Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes. J. Biol. Chem. 273:26765-26771.
44. Cases, S., et al. 1998. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc. Natl. Acad. Sci. U. S. A. 95:13018-13023.
45. Cases, S., et al. 2001. Cloning of dgat2, a second mammalian diacylglycerol acyltransferase, and related family members. J. Biol. Chem. 276:38870-38876.
46. Lardizabal, K.D., et al. 2001. Dgat2 is a new diacylglycerol acyltransferase gene family: purification, cloning, and expression in insect cells of two polypeptides from mortierella ramanniana with diacylglycerol acyltransferase activity. J. Biol. Chem. 276:38862-38869.
47. Meegalla, R.L., Billheimer, J.T., and Cheng, D. 2002. Concerted elevation of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin. Biochem. Biophys. Res. Commun. 298:317-323.
48. Smith, S.J., et al. 2000. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat. Genet. 25:87-90.
49. Stone, S.J., et al. 2004. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J. Biol. Chem. 279:11767-11776.
50. Yen, C.L., et al. 2005. The triacylglycerol synthesis enzyme DGAT1 also catalyzes the synthesis of diacylglycerols, waxes, and retinyl esters. J. Lipid Res. 46:1502-1511.
51. Orland, M.D., et al. 2005. Acyl coenzyme A dependent retinol esterification by acyl coenzyme A: diacylglycerol acyltransferase 1. Biochim. Biophys. Acta. 1737:76-82.
52. Ikeda, S., et al. 2002. Up-regulation of SREBP-1c and lipogenic genes in skeletal muscles after exercise training. Biochem. Biophys. Res. Commun. 296:395-400.
53. Avignon, A., et al. 1996. Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis. Diabetes. 45:1396-1404.
54. Schmitz-Peiffer, C., et al. 1997. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes. 46:169-178.
55. Itani, S.I., et al. 2000. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes. 49:1353-1358.
56. Itani, S.I., et al. 2002. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes. 51:2005-2011.
57. Griffin, M.E., et al. 1999. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 48:1270-1274.
58. Kim, J.K., et al. 2004. PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114:823-827. doi:10.1172/JCI200422230.
59. Farese, R.V., Sajan, M.P., and Standaert, M.L. 2005. Atypical protein kinase C in insulin action and insulin resistance. Biochem. Soc. Trans. 33:350-353.
60. Kaneki, M., et al. 1999. Functional role for protein kinase Cbeta as a regulator of stress-activated protein kinase activation and monocytic differentiation of myeloid leukemia cells. Mol. Cell. Biol. 19:461-470.
61. Werlen, G., et al. 1998. Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 17:3101-3111.
62. Aguirre, V., et al. 2000. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275:9047-9054.
63. Aguirre, V., et al. 2002. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277:1531-1537.
64. Trushin, S.A., et al. 1999. Protein kinase C and calcineurin synergize to activate IkappaB kinase and NF-kappaB in T lymphocytes. J. Biol. Chem. 274:22923-22931.
65. Gao, Z., et al. 2002. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J. Biol. Chem. 277:48115-48121.
66. Chen, H.C., et al. 2002. Analysis of energy expenditure at different ambient temperatures in mice lacking DGAT1. Am. J. Physiol. Endocrinol. Metab. 284:E213-E218.
67. Chen, H.C., et al. 2002. Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1. J. Clin. Invest. 109:1049-1055. doi:10.1172/JCI200214672.
68. Chen, H.C., et al. 2004. Role of adipocyte-derived factors in enhancing insulin signaling in skeletal muscle and white adipose tissue of mice lacking Acyl CoA:diacylglycerol acyltransferase 1. Diabetes. 53:1445-1451.
69. Chen, H.C., et al. 2003. Obesity resistance and enhanced glucose metabolism in mice transplanted with white adipose tissue lacking acyl CoA:diacylglycerol acyltransferase 1. J. Clin. Invest. 111:1715-1722. doi:10.1172/JCI200315859.
70. Listenberger, L.L., et al. 2003. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. U. S. A. 100:3077-3082.
71. Haemmerle, G., et al. 2006. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 312:734-737.
72. Serra, C., et al. 2003. Transgenic mice with dominant negative PKC-theta in skeletal muscle: a new model of insulin resistance and obesity. J. Cell. Physiol. 196:89-97.
73. Gao, Z., et al. 2007. Inactivation of PKCtheta leads to increased susceptibility to obesity and dietary insulin resistance in mice. Am. J. Physiol. Endocrinol. Metab. 292:E84-E91.
74. Bronfman, M., Morales, M.N., and Orellana, A. 1988. Diacylglycerol activation of protein kinase C is modulated by long-chain acyl-CoA. Biochem. Biophys. Res. Commun. 152:987-992.
75. Summers, S.A., et al. 1998. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol. Cell. Biol. 18:5457-5464.
76. Schmitz-Peiffer, C., Craig, D.L., and Biden, T.J. 1999. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J. Biol. Chem. 274:24202-24210.
77. Couplan, E., et al. 2002. High level of uncoupling protein 1 expression in muscle of transgenic mice selectively affects muscles at rest and decreases their IIb fiber content. J. Biol. Chem. 277:43079-43088.
78. Yu, Y.H., et al. 2002. Posttranscriptional control of the expression and function of diacylglycerol acyltransferase-1 in mouse adipocytes. J. Biol. Chem. 277:50876-50884.
79. Chen, N., et al. 2005. Whole-body insulin resistance in the absence of obesity in FVB mice with overexpression of Dgat1 in adipose tissue. Diabetes. 54:3379-3386.
80. Blaner, W.S. 1990. Radioimmunoassays for retinolbinding protein, cellular retinol-binding protein, and cellular retinoic acid-binding protein. Methods Enzymol. 189:270-281.
81. Liu, L., et al. 2001. Nuclear factor kappa B is involved in lipopolysaccharide-stimulated induction of interferon regulatory factor-1 and GAS/GAF DNA-binding in human umbilical vein endothelial cells. Br. J. Pharmacol. 134:1629-1638.